Clinical trial
A Study of BMS-562086 in Patients With Irritable Bowel Syndrome
NCT00399438 · Bristol-Myers Squibb, Industry · Completed
Key facts
| NCT number | NCT00399438 |
|---|---|
| Title | A Study of BMS-562086 in Patients With Irritable Bowel Syndrome |
| Official title | A Dose-Ranging Study of the Pharmacodynamic Effects of BMS-562086 on Gastrointestinal Transit in Women With Diarrhea-Predominant Irritable Bowel Syndrome |
| Lead sponsor | Bristol-Myers Squibb, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Irritable Bowel Syndrome |
| Intervention type | Drug |
| Interventions | Placebo, BMS-562086 |
| Enrollment | 39 |
| Start date | Dec 1, 2006 |
| Primary completion | Oct 1, 2007 |
| Completion | Jan 1, 2008 |
| First posted | Nov 14, 2006 |
| Last update posted | Sep 26, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: